apob

(redirected from apolipoprotein B-100)
Also found in: Medical.

apob

[′ā‚päb]
(meteorology)
An observation of pressure, temperature, and relative humidity taken aloft by means of an aerometeorograph; a type of aircraft sounding.
Mentioned in ?
References in periodicals archive ?
A major component in the hepatic synthesis of very low-density lipoprotein (VLDL) and hence LDL, is the transcription and translation of apolipoprotein B-100 (apo B100), the carrier protein of LDL.
Novel approaches to lipid-lowering therapy
No reports describing the use of mipomersen (Kynamro), an oligonucleotide inhibitor of apolipoprotein B-100 synthesis, in human pregnancy have been located.
The safety of lipid-lowering drugs in pregnancy
Data from an analysis of the study participants' atherogenic protein levels demonstrated that subjects experienced statistically significant reductions in lipoprotein(a) Lp(a) and apolipoprotein B-100 (apo B).
United States : Viking Therapeutics presents new clinical data on VK2809 in subjects with Elevated Cholesterol at American Heart Association Scientific Sessions 2016
Total cholesterol, HDL-c, TG, Apolipoprotein A-1 (Apo A-1), Apolipoprotein B-100 (Apo B-100) and glucose were measured in serum by standardized enzymatic automated methods in a PENTRA-400 autoanalyzer (ABX-Horiba Diagnostics, Montpellier, France).
Effects of low molecular weight procyanidin rich extract from French maritime pine bark on cardiovascular disease risk factors in stage-1 hypertensive subjects: Randomized, double-blind, crossover, placebo-controlled intervention trial
The complete cDNA and amino acid sequence of human apolipoprotein B-100. J.
A Genetic Variant (S4338N) in Apolipoprotein B Gene in Hypercholesterolemic Families from Pakistan
The Kynamro injection is an oligonucleotide inhibitor of apolipoprotein B-100 synthesis and has been approved in the US for use in patients with homozygous familial hypercholesterolemia, a genetic disease characterised by extreme cholesterol levels.
Kastle Therapeutics to acquire global development and commercialisation rights for Kynamro from Ionis Pharmaceuticals
Kynamro is an oligonucleotide inhibitor of apolipoprotein B-100 synthesis.
Ionis Pharmaceuticals Sells Kastle Therapeutics Rights to Kynamro
Serum apolipoprotein B-100 concentrations in healthy and diseased cattle.
APOLIPOPROTEIN B100 AND SOME LIPID COMPONENTS DURING TRANSITION PERIOD IN COWS UNDER HOT AND THERMONEUTRAL ENVIRONMENTAL CONDITIONS
VLDL is assembled on apolipoprotein B-100 (apoB100) and comprises 50% TG, 20% cholesterol esters, 15% phospholipids and 15% protein.
The influence of glucocorticoids on lipid and lipoprotein metabolism and atherosclerosis
Lp (a) is an LDL-like particle having an apolipoprotein (a) which is attached to apolipoprotein B-100 by a disulfide linkage.
Comparative study of lipoprotein (a) and lipid profile in chronic kidney disease patients with hemodialysis and without hemodialysis
Apolipoprotein B-100 gene Xba I polymorphism and cholesterol gallstone disease.
The effects of serum cholesterol, LDL, and HDL levels on gallstone cholesterol concentration
In this paper, we first review LDL, apolipoprotein B-100, the unique protein of LDL, and its oxidation sensitive components.
Low-density lipoprotein modified by myeloperoxidase in inflammatory pathways and clinical studies

Encyclopedia browser ?
Full browser ?